CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
53 hedge funds and large institutions have $63.2M invested in CASI Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.98% more ownership
Funds ownership: 1.14% → 2.12% (+0.98%)
Holders
53
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$4.14M | |
| 2 | +$268K | |
| 3 | +$247K | |
| 4 |
Morgan Stanley
New York
|
+$175K |
| 5 |
BlackRock
New York
|
+$163K |
Top Sellers
| 1 | -$132K | |
| 2 | -$117K | |
| 3 | -$104K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$75K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$39K |